The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer
暂无分享,去创建一个
J. Crow | A. Jones | J. Buscombe | Andrew J.W. Hilson | R. Barlow | J. Cwikła | S. Parbhoo | A. Deery | S. Kelleher
[1] H. Biersack,et al. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging , 1996, European Journal of Nuclear Medicine.
[2] A. Robidoux,et al. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] I. Mena,et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] D. Piwnica-Worms,et al. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. , 1995, Biochemistry.
[5] G. Giaccone,et al. Prognostic relevance of P-glycoprotein expression in breast cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] D. Piwnica-Worms,et al. Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein. , 1995, Journal of medicinal chemistry.
[7] J. Ballinger,et al. 99Tcm‐sestamibi as an agent for imaging P‐glycoprotein-mediated multi‐drug resistance: In vitro and in vivo studies in a rat breast tumour cell line and its doxirubicin‐resistant variant , 1995, Nuclear medicine communications.
[8] I. Mena,et al. Technical Aspects of Prone Dependent-Breast Scintimammography , 1994 .
[9] Shuu-Jiun Wang,et al. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses , 1994, European Journal of Nuclear Medicine.
[10] I. Mena,et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. , 1994, Journal of the American College of Surgeons.
[11] R. Kramer,et al. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. , 1993, Cancer research.
[12] R. Tiling,et al. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] E. Milan,et al. Evaluation of technetium-99m-sestamibi lung uptake: correlation with left ventricular function. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.